Relapse-free cure from multidrug-resistant tuberculosis in Germany

Jan Heyckendorf; Frank van Leth; Barbara Kalsdorf; Ioana D Olaru; Gunar Günther; Helmut J F Salzer; Elena Terhalle; Thierry Rolling; Georg Glattki; Marius Müller; Maren Schuhmann; Korkut Avsar; Christoph Lange

doi:10.1183/13993003.02122-2017

Relapse-free cure from multidrug-resistant tuberculosis in Germany

Eur Respir J. 2018 Feb 21;51(2):1702122. doi: 10.1183/13993003.02122-2017. Print 2018 Feb.

Authors

Jan Heyckendorf^{1

2

3}, Frank van Leth⁴, Barbara Kalsdorf^{5

2

3}, Ioana D Olaru^{5

6}, Gunar Günther⁷, Helmut J F Salzer^{5

2

3}, Elena Terhalle^{5

2

3}, Thierry Rolling^{2

8

9}, Georg Glattki¹⁰, Marius Müller¹¹, Maren Schuhmann¹², Korkut Avsar¹³, Christoph Lange^{5

2

3

14}

Affiliations

¹ Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany jheyckendorf@fz-borstel.de.
² German Center for Infection Research (DZIF), Germany.
³ International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.
⁴ Dept of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands.
⁵ Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.
⁶ Dept of Microbiology, University Hospitals of Leicester, Leicester, UK.
⁷ Dept of Medicine, University of Namibia School of Medicine, Windhoek, Namibia.
⁸ Sections of Infectious Diseases and Tropical Medicine, I Dept of Internal Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
⁹ Clinical Research Unit, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany.
¹⁰ Karl-Hansen-Klinik, Bad Lippspringe, Germany.
¹¹ Sankt Katharinen-Krankenhaus, Frankfurt, Germany.
¹² Thoraxklinik-Heidelberg, Heidelberg, Germany.
¹³ Asklepios Fachkliniken München-Gauting, Munich, Germany.
¹⁴ Dept of Medicine, Karolinska Institute, Stockholm, Sweden.

PMID: 29467205
DOI: 10.1183/13993003.02122-2017

No abstract available

Publication types

Letter
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't

MeSH terms

Antitubercular Agents / therapeutic use
Extensively Drug-Resistant Tuberculosis / drug therapy*
Follow-Up Studies
Germany / epidemiology
Humans
Prospective Studies
Recurrence
Remission Induction
Treatment Outcome
Tuberculosis, Multidrug-Resistant / drug therapy*
Tuberculosis, Multidrug-Resistant / epidemiology
Tuberculosis, Pulmonary / drug therapy

Substances

Antitubercular Agents